跳至主要内容
临床试验/NCT05656664
NCT05656664Enrolling By Invitation不适用

Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation: Reducing Toxicity and Exploring the Impact on Lung Health

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
100
试验地点
2
主要终点
Measurement of urine and blood arsenic metabolites

研究概览

简要总结

The purpose of this study is to evaluate the effects on folic acid supplementation in a population living in an environment with chronic arsenic exposure in Birmingham, Alabama.

详细描述

Folic acid supplementation effects urinary arsenic excretion. In this project investigators propose to investigate if oral folic acid dietary supplementation can increase urinary arsenic metabolite excretion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Study randomization will be performed by using a randomization scheme provided by the Investigational Drug Service (IDS). The randomization scheme will be held by IDS and concealed to investigators until the completion of the study.

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age
  • Resident of the superfund site
  • Clinically stable with no significant changes in general health status in the past 4 weeks prior to screening as assessed by the investigator
  • Provide written informed consent

排除标准

  • Pregnancy
  • Ongoing folic acid nutritional supplementation
  • Methotrexate use
  • Megaloblastic anemia
  • Alcoholic liver disease
  • Malabsorptive syndromes - celiac disease, inflammatory bowel disease

结局指标

主要结局

Measurement of urine and blood arsenic metabolites

时间窗: 12 weeks

Inorganic As (InAs) within humans undergoes a stepwise biotransformation reaction in which it is methylated to monomethyl-arsonic acid (MMAsIII), and dimethylarsinic acid (DMAsV) facilitating urinary excretion. This occurs via arsenic methyltransferase (AS3MT) using a methyl donor S-adenosylmethionine (SAM). In this pathway the one-carbon unit carried by 5-methyl-tetrahydrofolate (5-MTHF) is transferred to homocysteine to form methionine, which is activated to SAM. Complete methylation to DMAsV is critical as higher proportion of MMAs(III+V) are associated with skin lesions, peripheral vascular disease, atherosclerosis, and cancers. We will measure levels of InAs, total DMA and MMA in the urine and blood of the study subjects at baseline and 12 weeks. Outcomes will be reported in percentage (%) of InAs, DMA and MMA in blood and urine.

次要结局

  • Pooled Cohort Probability Score(12 weeks)
  • Respiratory Symptom Questionnaire(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kevin Dsouza, MD

Assistant Professor

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验